Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Transplantation and Cellular Therapy
|
October 3, 2025
Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation
Shannon R McCurdy, Scott R Solomon, Brian C Shaffer, et al.
The Lancet. Oncology
|
January 4, 2015
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
Mohammed Z H Farooqui, Janet Valdez, Sabrina Martyr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2019
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T Kim, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Transplantation and Cellular Therapy
|
October 3, 2025
Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation
Shannon R McCurdy, Scott R Solomon, Brian C Shaffer, et al.
The Lancet. Oncology
|
January 4, 2015
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
Mohammed Z H Farooqui, Janet Valdez, Sabrina Martyr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2019
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T Kim, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Page
of 2